Literature DB >> 21663795

Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast.

Christina Scheel1, Elinor Ng Eaton, Sophia Hsin-Jung Li, Christine L Chaffer, Ferenc Reinhardt, Kong-Jie Kah, George Bell, Wenjun Guo, Jeffrey Rubin, Andrea L Richardson, Robert A Weinberg.   

Abstract

The epithelial-mesenchymal transition (EMT) has been associated with the acquisition of motility, invasiveness, and self-renewal traits. During both normal development and tumor pathogenesis, this change in cell phenotype is induced by contextual signals that epithelial cells receive from their microenvironment. The signals that are responsible for inducing an EMT and maintaining the resulting cellular state have been unclear. We describe three signaling pathways, involving transforming growth factor (TGF)-β and canonical and noncanonical Wnt signaling, that collaborate to induce activation of the EMT program and thereafter function in an autocrine fashion to maintain the resulting mesenchymal state. Downregulation of endogenously synthesized inhibitors of autocrine signals in epithelial cells enables the induction of the EMT program. Conversely, disruption of autocrine signaling by added inhibitors of these pathways inhibits migration and self-renewal in primary mammary epithelial cells and reduces tumorigenicity and metastasis by their transformed derivatives.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21663795      PMCID: PMC3930331          DOI: 10.1016/j.cell.2011.04.029

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  27 in total

1.  Activin-Nodal signaling is involved in propagation of mouse embryonic stem cells.

Authors:  Kazuya Ogawa; Akira Saito; Hisanori Matsui; Hiroshi Suzuki; Satoshi Ohtsuka; Daisuke Shimosato; Yasuyuki Morishita; Tetsuro Watabe; Hitoshi Niwa; Kohei Miyazono
Journal:  J Cell Sci       Date:  2007-01-01       Impact factor: 5.285

2.  Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways.

Authors:  Tamer T Onder; Piyush B Gupta; Sendurai A Mani; Jing Yang; Eric S Lander; Robert A Weinberg
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

3.  Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis.

Authors:  Esmeralda Casas; Jihoon Kim; Andrés Bendesky; Lucila Ohno-Machado; Cecily J Wolfe; Jing Yang
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

4.  Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells.

Authors:  David A Rider; Christian Dombrowski; Amber A Sawyer; Grace H B Ng; David Leong; Dietmar W Hutmacher; Victor Nurcombe; Simon M Cool
Journal:  Stem Cells       Date:  2008-03-20       Impact factor: 6.277

5.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

6.  The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.

Authors:  Samudra K Dissanayake; Michael Wade; Carrie E Johnson; Michael P O'Connell; Poloko D Leotlela; Amanda D French; Kavita V Shah; Kyle J Hewitt; Devin T Rosenthal; Fred E Indig; Yuan Jiang; Brian J Nickoloff; Dennis D Taub; Jeffrey M Trent; Randall T Moon; Michael Bittner; Ashani T Weeraratna
Journal:  J Biol Chem       Date:  2007-04-10       Impact factor: 5.157

7.  An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells.

Authors:  Anna Bafico; Guizhong Liu; Luba Goldin; Violaine Harris; Stuart A Aaronson
Journal:  Cancer Cell       Date:  2004-11       Impact factor: 31.743

8.  Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines.

Authors:  T Pukrop; F Klemm; Th Hagemann; D Gradl; M Schulz; S Siemes; L Trümper; C Binder
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-28       Impact factor: 11.205

9.  Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.

Authors:  Christine M Fillmore; Charlotte Kuperwasser
Journal:  Breast Cancer Res       Date:  2008-03-26       Impact factor: 6.466

10.  Generation of breast cancer stem cells through epithelial-mesenchymal transition.

Authors:  Anne-Pierre Morel; Marjory Lièvre; Clémence Thomas; George Hinkal; Stéphane Ansieau; Alain Puisieux
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

View more
  437 in total

1.  Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.

Authors:  Yuan Liu; Marty W Mayo; Aizhen Xiao; Emily H Hall; Elianna B Amin; Kyuichi Kadota; Prasad S Adusumilli; David R Jones
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

Review 2.  Control dominating subclones for managing cancer progression and posttreatment recurrence by subclonal switchboard signal: implication for new therapies.

Authors:  Shengwen Calvin Li; Katherine L Lee; Jane Luo
Journal:  Stem Cells Dev       Date:  2011-11-02       Impact factor: 3.272

Review 3.  Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.

Authors:  Robert Strauss; Petra Hamerlik; André Lieber; Jiri Bartek
Journal:  Mol Ther       Date:  2012-02-07       Impact factor: 11.454

4.  CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells.

Authors:  Akihiro Tsuyada; Amy Chow; Jun Wu; George Somlo; Peiguo Chu; Sofia Loera; Thehang Luu; Arthur Xuejun Li; Xiwei Wu; Wei Ye; Shiuan Chen; Weiying Zhou; Yang Yu; Yuan-Zhong Wang; Xiubao Ren; Hui Li; Peggy Scherle; Yukio Kuroki; Shizhen Emily Wang
Journal:  Cancer Res       Date:  2012-04-03       Impact factor: 12.701

Review 5.  TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1.

Authors:  Breege V Howley; Philip H Howe
Journal:  Cytokine       Date:  2018-02-01       Impact factor: 3.861

Review 6.  Naturally occurring compounds acting as potent anti-metastatic agents and their suppressing effects on Hedgehog and WNT/β-catenin signalling pathways.

Authors:  L Farahmand; B Darvishi; K Majidzadeh-A; A Madjid Ansari
Journal:  Cell Prolif       Date:  2016-09-27       Impact factor: 6.831

7.  PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma.

Authors:  A Asgarova; K Asgarov; Y Godet; P Peixoto; A Nadaradjane; M Boyer-Guittaut; J Galaine; D Guenat; V Mougey; J Perrard; J R Pallandre; A Bouard; J Balland; C Tirole; O Adotevi; E Hendrick; M Herfs; P F Cartron; C Borg; E Hervouet
Journal:  Oncoimmunology       Date:  2018-02-01       Impact factor: 8.110

8.  Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.

Authors:  Jian Shi; Yifan Wang; Lei Zeng; Yadi Wu; Jiong Deng; Qiang Zhang; Yiwei Lin; Junlin Li; Tiebang Kang; Min Tao; Elena Rusinova; Guangtao Zhang; Chi Wang; Haining Zhu; Jun Yao; Yi-Xin Zeng; B Mark Evers; Ming-Ming Zhou; Binhua P Zhou
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

Review 9.  Circulating tumor cells: from bench to bedside.

Authors:  Marija Balic; Anthony Williams; Henry Lin; Ram Datar; Richard J Cote
Journal:  Annu Rev Med       Date:  2012-10-18       Impact factor: 13.739

10.  Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells.

Authors:  Arindam Banerjee; PengXu Qian; Zheng-Sheng Wu; Xiaoge Ren; Michael Steiner; Nicola M Bougen; Suling Liu; Dong-Xu Liu; Tao Zhu; Peter E Lobie
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.